
|Articles|June 26, 2018
Top 5 Key Takeaways from ASCO 2018
Author(s)Krista Rossi
The 2018 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, Illinois, June 1-5, 2018, featured data from numerous studies and advancements being made in rare cancers. Here are 5 key takeaways from the meeting.
Advertisement
The
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
OMA 2026 Recap: Pediatrics, Retention, and Lifestyle Changes in Obesity
2
A Real-World Case: Initiating Ritlecitinib After Years of Untreated Disease
3
Choosing Among Approved JAK Inhibitors: Baricitinib, Ritlecitinib, and Deuruxolitinib
4
CX11 Shows Weight Loss in Phase 2 Obesity Trial, Corxel Reports
5



































































